期刊文献+

重组改良型人膜联蛋白的核素标记及体内显像的实验研究 被引量:2

Experiment research of radioisotope labeling for His-Annexin V and scintigraphy in vivo
暂未订购
导出
摘要 目的探讨放射性核素标记重组改良型人膜联蛋白V(His-AnnexinV)的方法,并应用于体内显像的研究。方法取不同剂量的His-AnnexinV以生理盐水溶解,加入缓冲液,再分别加入不同剂量的还原剂SnCl2,然后在其中分别加入不同活度的99mTcO4-进行直接标记,混匀,条件均为常温下震荡,37°孵化,取出自然冷却到室温。结果 His-AnnexinV500μg,加入40μg还原剂SnCl2,然后加入185~296MBq99mTcO4-进行直接标记,标记率可达到95%以上;99mTc-His-AnnexinV在动脉粥样硬化兔模型中,可有效检测动脉粥样硬化斑块。结论 99mTc直接标记His-AnnexinV,标记率高,并可成为动脉粥样硬化斑块的显像剂。 ObjectiveTo investigate labeling methods of 99mTc-His-Annexin V,and to apply this method to imaging research in vivo.MethodsTo get different dose His-AnnexinV,buffer solution and then different doses of SnCl2 were added.And solution was mixed with 99mTcO4-of different activity for direct labeling.and then shaken in common temperature,incubated in 37℃ and natural cooled at room temperature.ResultsA total of 500μg 99mTc-His-AnnexinV were added with 40μg SnCl2 add 185~370 MBq 99mTcO4 for direct labeling,the labeling rate arrived at 95%.And 99mTc-His-AnnexinV could effectively detect arthrosclerosis plaque for rabbit arthrosclerosis model.ConclusionThe labeling rate of 9mTc-His-Annehin V is high by direct method,and it can become a kind of noninvasive method for detecting atherosclerotic plaque.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第17期2579-2581,2586,共4页 China Journal of Modern Medicine
基金 辽宁省教育厅基金(No:20060514)
关键词 膜联蛋白V 放射性标记 核素显像 Annexin V radioisotope labeling radionuclide imaging
  • 相关文献

参考文献10

  • 1JOHNSON LL, SCHOFIELD L, DONAHAY T, et al. ^99mTc-Annexin V imaging for in vivo detection of athemsclerotic lesions in porcine coronary arteries[J]. J Nucl Med, 2005, 46: 1186-1193.
  • 2BOGDANOC A, SIMONOVA J, W EISSLEDER R. Design of metal binding green fluorescent protein variants[J]. Biochem Biophys Acta, 1998, 1397: 56-64.
  • 3兰晓莉,张永学,安锐,高再荣,何勇,曹国祥.人膜联蛋白Ⅴ的表达及核素标记[J].华中科技大学学报(医学版),2005,34(5):517-520. 被引量:3
  • 4BEST PJ, HASDAI D, SANGIOORGI G, et al. Apoptosis. Basic conerpts and implications in coronary artery disease [J]. Arterioscler Thromb Vasc Biol, 1999, 19: 14-22.
  • 5BUCK AK, HALTERG, SCHINM EISTER H, et al. Imaging proliferation in lung tumors with PET [J]. J Nucl Med, 2003, 44 (9): 1426-1431.
  • 6王晓花,章建程.动脉粥样硬化动物模型研究进展[J].海军医学杂志,2007,28(2):175-177. 被引量:4
  • 7REKHTER MD, HICKS GW, BRAMMER DW, et al. Animal model that mimics atherosclerotic plaque rupture [J]. Circ Res, 1998, 83: 705-713.
  • 8LAHORTE CM, VANDERHEYDEN JL, STEINMETZ N, et al. Apoptosis-detecting radioligands: current state of the art and future perspectives [J]. Eur J Nucl Med Mol Imaging, 2004, 31: 887-919.
  • 9ZIJLSTRA S, GUNAWAN J, BURCHERT W. Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET[J]. Appl Radiat Isot, 2003, 58: 201-207.
  • 10贾支俊,冯雪凤,杨翔,华子春,申景涛,郭万华.^(99)Tc^m-H-Annexin V动物体内分布及显像[J].中国临床医学影像杂志,2008,19(1):56-58. 被引量:6

二级参考文献36

共引文献8

同被引文献22

  • 1QAZ1 AS, SUN M, HUANG Y, et al. Subcellular proleomics:determination of specific location and expression levels of lym- phatic metastasis associated proteins in hepatocellular carcinoma by subcellular fractionation[J]. Biomed Pharmacother, 2011, 65(6): 407-416.
  • 2SUN MZ, LIU S, TANG J, et al. Proteomics analysis of two mice hepatocarcinoma ascites syngeneic cell lines with high and low lymph node metastasis rates provide potential protein markers for tumor malignancy attributes to lymphatic metastasis[J]. Pro- teomics, 2009, 9(12): 3285-3302.
  • 3ZHANG J, SONG M, WANG J, et al. Euoyl coenzyme A hy- dratase 1 is an important factor in the lymphatic metastasis of tumors[J]. Biomed Pharmacother, 2011, 65(3): 157-162.
  • 4TOROSYAN Y, DOBI A, GLASMAN M, et al. Role of mul- ti-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells[J]. Oncogene, 2010, 29(17): 2457 -2466.
  • 5TOROSYAN y, SIMAKOVA O, NAGA S, et al. Annexin-A7 protects normal prostate ceils and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells[J]. Int J Cancer, 2009, 125: 2528-2539.
  • 6SRIVASTAVA M, TOROSYAN Y, RAFFELD M, et al. ANXA7 expression represents hormone-relevant tumor suppression in dif- ferent cancers[J]. Int J Cancer, 2007, 121: 2628-2636.
  • 7TANIUCHI K, YOKOTANI K, SAIBARA T. BART inhibits pancreatic cancer cell invasion by PKC α inactivation through bind- ing to ANXT[J]. PLoS One, 2012, 7(4): 35674.
  • 8BREDEL M, SCHOLTENS DM, HARSH GR, et al. A network model of a cooperative genetic landscape in brain tumors[J]. JA- MA, 2009, 302(3): 261-275.
  • 9JI H, MORITZ RL, KIM YS, et al. Analysis of ras-induced oncogenic transformation of NIH-3T3 ceils using differential dis- play 2-DE proteomics[J]. Electrophoresis, 2007, 28: 1997-2008.
  • 10CLAUDIA H, CHRISTOPH SC, GISELA L, et al. Function, expression and localization of annexin A7 in platelets and red blood ceils: Insights derived from an annexin A7 mutant mouse [J]. BMC Biochemistry, 2003, 4: 8-18.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部